Genesis Healthcare, Inc.
GEN
GEN was delisted on the 25th of March, 2021.
78 hedge funds and large institutions have $113M invested in Genesis Healthcare, Inc. in 2015 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 31 increasing their positions, 22 reducing their positions, and 21 closing their positions.
258% more call options, than puts
Call options by funds: $666K | Put options by funds: $186K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
41% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 22
12% more capital invested
Capital invested by funds: $100M → $113M (+$12.5M)
10% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 21
3% less funds holding
Funds holding: 80 → 78 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
+$29.4M |
| 2 |
CPA
Columbia Pacific Advisors
Seattle,
Washington
|
+$18.8M |
| 3 |
DM
Deerfield Management
New York
|
+$4.64M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.95M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.08M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$1.89M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.57M |
| 3 |
MAM
Martingale Asset Management
Boston,
Massachusetts
|
-$871K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$856K |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$848K |
GEN Hedge Fund Activity: Q2 2015 in Review
78 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q2 2015, worth a combined $113M — up 12% from $100M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of GEN and 19 opened new positions — a net loss of 2 holders — while 22 trimmed existing stakes and 31 added.
The largest buyer was HighTower Advisors, opening a new position worth an estimated $29.4M. The largest seller was JP Morgan Chase, exiting entirely with an estimated $1.89M sold.
- 78 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q2 2015, down from 80 in Q1 2015.
- Funds reported $113M of Genesis Healthcare, Inc. stock for Q2 2015, up 12% quarter-over-quarter.
- 19 funds opened new Genesis Healthcare, Inc. positions in Q2 2015 and 21 closed out, a net change of -2 holders.
- The largest Genesis Healthcare, Inc. buyer in Q2 2015 was HighTower Advisors, an estimated $29.4M added.
- The largest Genesis Healthcare, Inc. seller in Q2 2015 was JP Morgan Chase, an estimated $1.89M sold.
Based on aggregated 13F filings for Q2 2015.